Dependence of low-frequency sonophoresis on ultrasound parameters; distance of the horn and intensity.

Sonophoresis at a frequency of 20 kHz has been shown to enhance transdermal drug delivery, a phenomenon referred to as low-frequency sonophoresis. This study provides an investigation of the dependence of low-frequency sonophoresis on various ultrasound parameters, including the distance of the horn from the skin, intensity, and frequency. We performed in vitro experiments with full thickness pig skin to measure enhancements of skin conductivity and drug permeability. Ultrasound was applied to pretreat the skin using a sonicator operating at a frequency of either 20 or 40 kHz. We also measured pitting of aluminum foil to measure cavitation, which is the principal mechanism of low-frequency sonophoresis. The skin conductivity enhancement was found to be inversely proportional to the distance of the horn from the skin. As the intensity increased, skin conductivity enhancement also increased up to a certain threshold, and then dropped off. The intensities (I(max)) at which maximum enhancement occur are about 14 W/cm2 for 20 kHz and 17 W/cm2 for 40 kHz. These findings may be useful in optimizing low-frequency sonophoresis. Overall, the dependence of transport on ultrasound parameters is similar to that of aluminum foil pitting. These results support the role of cavitation in low-frequency sonophoresis.

[1]  R. Guy,et al.  Sonophoresis. II. Examination of the Mechanism(s) of Ultrasound-Enhanced Transdermal Drug Delivery , 1992, Pharmaceutical Research.

[2]  R. Guy,et al.  Sonophoresis. I. The Use of High-Frequency Ultrasound to Enhance Transdermal Drug Delivery , 1992, Pharmaceutical Research.

[3]  Jagdish Singh,et al.  Topical iontophoretic drug delivery: Pathways, principles, factors, and skin irritation , 1996, Medicinal research reviews.

[4]  S. Mitragotri,et al.  Ultrasound-mediated transdermal protein delivery , 1995, Science.

[5]  S. Hattori,et al.  Relation between impact load and the damage produced by cavitation bubble collapse , 1995 .

[6]  M. Prausnitz,et al.  Non-Invasive Assessment and Control of Ultrasound-Mediated Membrane Permeabilization , 1998, Pharmaceutical Research.

[7]  K. Tachibana Transdermal Delivery of Insulin to Alloxan-Diabetic Rabbits by Ultrasound Exposure , 1992, Pharmaceutical Research.

[8]  M. Prausnitz Do high-voltage pulses cause changes in skin structure? , 1996 .

[9]  J Kost,et al.  Effect of ultrasound on transdermal drug delivery to rats and guinea pigs. , 1989, The Journal of clinical investigation.

[10]  S. Mitragotri,et al.  A mechanistic study of ultrasonically-enhanced transdermal drug delivery. , 1995, Journal of pharmaceutical sciences.

[11]  J. Weaver,et al.  Electroporation of mammalian skin: a mechanism to enhance transdermal drug delivery. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Aarti Naik,et al.  Iontophoretic drug delivery. , 2004, Advanced drug delivery reviews.

[13]  T Terahara,et al.  Determination of threshold energy dose for ultrasound-induced transdermal drug transport. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[14]  J. Weaver,et al.  Analysis of enhanced transdermal transport by skin electroporation , 1995 .

[15]  W. Gaertner Frequency Dependence of Ultrasonic Cavitation , 1954 .